Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells

Clinical trial NCT01355913 · COMPLETED

Trial details

NCT number: NCT01355913
Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndromes (MDS)Chromosmal Aberrations Karyotype Evolution Rare Abnormalities Cytogenetic Monitoring

Start date: 2008-10-01
Primary completion: 2016-10-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.